EP3189073

CELLECTIS
Application Number
EP15757289A
Filing Date
Sep 3, 2015
Status
Granted And Under Opposition
Nov 22, 2019
Grant Date
Dec 25, 2019
External Links
Slate, Register

Biblio Summary

The patent EP3189073B1 was granted on Dec 25, 2019 by Cellectis The patent is currently Granted And Under Opposition.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

OXFORD BIOMEDICA (UK) LIMITEDSep 24, 2020ADMISSIBLE

The table below shows the patents of Cellectis that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2997141Cd19 Specific Chimeric Antigen Receptor And Uses ThereofOct 12, 20221
EP3116902Method For Generating T-Cells Compatible For Allogenic TransplantationJan 1, 20204
EP3126390Cd33 Specific Chimeric Antigen Receptors For Cancer ImmunotherapyOct 16, 20191